Press – Maiwald

Press Coverage

15 Apr 2025 - Press Coverage

Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics

Cyprumed GmbH and Merck & Co., Inc. have entered a Non-Exclusive License and Option Agreement to develop oral formulations of peptides using Cyprumed’s drug delivery technology. MSD gains global non-exclusive rights...

2 Apr 2025 - Press Coverage

Managing IP names Maiwald one of the leading IP law firms in Germany

The market analysis by Managing IP and the IP STARS ranking 2024 confirm this: The German market for intellectual property remains dynamic and highly competitive. Especially in the field of patent law, numerous law firms were able to maintain and expand their leading positio...

11 Mar 2025 - Press Coverage

Roche gets Illumina unit’s DNA testing patent revoked

Roche has successfully persuaded a European appeals panel to revoke a patent held by Illumina’s subsidiary, Verinata Health, for detecting fetal DNA in maternal blood. The European Patent Office (EPO) ruled that the patent lacked an inventive step, as a prior application f...

All press coverage

Maiwald press releases

25 Mar 2025 - Press Release

Roche gets Illumina unit’s DNA testing patent revoked

A European Patent Office board of appeal said in a ruling published on March 10th that Roche Diagnostics GmbH proved Verinata Health Inc.'s blueprint lacks an inventive step over an earlier international patent application setting out a similar way of testing "free-floating ...

11 Aug 2023 - Press Release

Another success for Maiwald and betapharm Arzneimittel GmbH

We are happy to report that the oppositions filed by our client betapharm and eight other generics manufacturers against Novartis patent EP 3 351 246 were successful; the Board of Appeal of the European Patent Office revoked the Novartis patent for lack of inventive step (fi...

20 Dec 2022 - Press Release

Maiwald wins important opposition case for its client Acetate International LLC at the European Patent Office

Maiwald GmbH in Munich has achieved an important victory for its client Acetate International LLC at the European Patent Office. Acetate International LLC is part of the Celanese group which has a long history of producing cellulose acetate products for commercial applicatio...

All press releases

Maiwald in the press

Press Coverage

Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics

Managing IP names Maiwald one of the leading IP law firms in Germany

Roche gets Illumina unit’s DNA testing patent revoked

Maiwald press releases

Roche gets Illumina unit’s DNA testing patent revoked

Another success for Maiwald and betapharm Arzneimittel GmbH

Maiwald wins important opposition case for its client Acetate International LLC at the European Patent Office

Press Contact

Dr. Eva Dörner